7d
Barchart on MSNIs Quest Diagnostics Stock Outperforming the S&P 500?With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...
StockStory.org on MSN14h
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...
Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive ...
The Quest Diagnostics office, at 1074 Idaho St., will have two phlebotomists when fully staffed and expects to draw blood ...
“The enthusiasm into AI actually carries over into everything, which effectively impacts all startups,” said Kohli when asked ...
Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...
(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...
With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services in the United States and internationally. It operates through two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results